Studies in knockout mice suggest that the clot busting drug tPA harms neurons; experience in acute ischemic stroke patients says otherwise (pages 228–231).
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Post-transcriptional inactivation of matrix metalloproteinase-12 after focal cerebral ischemia attenuates brain damage
Scientific Reports Open Access 08 May 2015
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Huang, Z. et al. Enlarged infarcts in endothelial nitric oxide synthase knockout mice are attenuated by nitro-L-arginine. J. Cereb. Blood Flow Metab. 16, 981–987 (1996).
Sappino, A.-P. et al. Extracellular proteolysis in the adult murine brain. J. Clin. Invest. 92, 679–685 (1993).
Levin, E.G. & del Zoppo, G.j. Localization of tissue plasminogen activator in the endothelium of a limited number of vessels. Am. J. Pathol. 144, 855–861 (1994).
Tsirka, S.E., Gualandris, A., Amaral, D.G. & Strickland, S. Excitotoxin-induced neuronal degeneration and seizure are mediated by tissue plasminogen activator. Nature 377, 340–344 (1995).
Tsirka, S.E., Rogove, A.D. & Strickland, S., Neural cell death and tPA. Nature 384, 123–124 (1996).
The National Institutes of Neurological Disorders and Stroke rtPA Stroke Study Group. Tissue plasminogen activator for acute ischemic stroke. N. Engl. J. Med. 333,1581–1587 (1995).
Wang, Y.F. et al. Tissue plasminogen activator (tPA) increases neuronal damage after focal cerebral ischemia in wild-type and tPA-deficient mice. Nature Med. 4, 228–231 (1998).
del Zoppo, G.j. et al. PROACT: A phase II randomized trial of recombinant pro-urokinase by direct arterial delivery in acute middle cerebral artery stroke. Stroke (in the press).
Hacke, W. et al. Intravenous thrombolysis with recombinant tissue plasminogen activator for acute hemispheric stroke. The European Cooperative Acute Stroke Study (ECASS). JAMA 274, 1017–1025 (1995).
Chen, Z.-L. & Strickland, S. Neuronal death in the hippocampus is promoted by plasmin-catalyzed degradation of laminin. Cell 91, 917–925 (1997).
Pulsinelli, W.A. & Duffy, T.E. Regional energy balance in rat brain after transient forebrain ischemia. J. Neurochem. 40, 1500–1503 (1983).
Tagaya, M. et al. DNA scission following focal brain ischemia: Temporal differences in two species. Stroke 28, 1245–1254 (1997).
Korninger, C. & Collen, D. Studies on the specific fibrinolytic effect of human extrinsic (tissue-type) plasminogen activator in human blood and in various animal species in vitro. Thromb. Haemost. 46, 561–565 (1981).
McKee, P.A., Lemmon, W.B. & Hampton, J.W. Streptokinase and urokinase activation of human, chimpanzee, and baboon plasminogen. Thromb. Diath. Haemorrh. 26, 512–522 (1971).
del Zoppo, G.J., Copeland, B.R., Anderchek, K., Hacke, W. & Koziol, J.A. Hemorrhagic transformation following tissue plasminogen activator in experimental cerebral infarction. Stroke 21, 596–601 (1990).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Del Zoppo, G. tPA: A neuron buster, too?. Nat Med 4, 148–150 (1998). https://doi.org/10.1038/nm0298-148
Issue Date:
DOI: https://doi.org/10.1038/nm0298-148
This article is cited by
-
Post-transcriptional inactivation of matrix metalloproteinase-12 after focal cerebral ischemia attenuates brain damage
Scientific Reports (2015)
-
Lipoprotein receptor–mediated induction of matrix metalloproteinase by tissue plasminogen activator
Nature Medicine (2003)
-
Is tissue plasminogen activator a threat to neurons?
Nature Medicine (2001)